Sarepta Voluntarily Stops Shipments Of Elevidys After Previously Refusing FDA Request

Discussions Ongoing With The Agency

Shipments to non-ambulatory DMD patients already are paused, but now Elevidys will not be shipped to ambulatory boys (Shutterstock)

More from Gene Therapies

More from Advanced Therapies